An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
Upcoming Clinical Trials
-
Nicholas ButowskiSiren BiotechnologyNot yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade GliomasUnited States
-
State University of New York at BuffaloNot yet recruitingPatient EngagementUnited States
-
Poitiers University HospitalNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
University of California, IrvineRecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer MetastaticUnited States
-
Qualia Life SciencesRecruiting
-
Guangdong Raynovent Biotech Co., LtdNot yet recruiting
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationRecruitingAdults | Low Vision Digital Assistance | Visual ImpairmentsHong Kong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
Sun Yat-sen UniversityNot yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
-
AIMEDBIOBoehringer IngelheimNot yet recruitingSolid TumoursFrance, Japan, South Korea, United States, Australia